Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10507211
Treatment for hereditary neuropathy with liability to pressure palsies (HNPP)
granted -
US 10508122
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
granted -
US 10507187
Regenerative tissue grafts and methods of making same
granted -
US 10507239
V1/V2 fragments of a HIV-1 envelope glycoprotein
granted -
US 10507237
Attenuated African swine fever virus vaccine
granted -
US 10508083
Substituted piperidine compound and use thereof
granted -
US 10507284
Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications
granted -
US 10508129
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10508140
Peptide having hair growth-promoting activity and/or melanin generation-promoting activity, and use thereof
granted -
US 10508136
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 2019374518
TREATMENT OF MIGRAINE
granted -
US 2019374520
TREATMENT OF MIGRAINE
granted -
EP 3576795
ORALES SCHILDDRÜSENTHERAPEUTIKUM
granted -
US 10500194
Covalent small molecule DCN1 inhibitors and therapeutic methods using the same
granted -
US 10501558
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
granted -
US 10501511
Low molecular polypeptide for preventing and treating inflammation and use thereof
granted -
US 10501444
Inhibitors of influenza virus replication, application methods and uses thereof
granted -
US 10500284
Pharmaceutical formulation
granted -
US 10500277
Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
granted -
US 10500264
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted -
US 10500261
Synthetic antigen constructs against campylobacter jejuni
granted -
US 10499682
Micronutrient formulation in electronic cigarettes
granted -
US 10500167
Droplet-embedded microfibers, and methods and devices for preparing and using same
granted -
US 10501439
DNA-PK inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.